Treatment of High-Burden Thrombus in a Large Right
Coronary Artery
| | | |
Treatment of a coronary artery with a high burden
of thrombus in the setting of myocardial infarction poses significant
challenges to the operator. Furthermore, a high thrombus burden
present in an abnormal aneurysmal artery poses an even greater
obstacle. We report a unique case of a 30 year-old-male presenting
with an acute myocardial infarction with a heavy thrombus burden
in an aneurysmal right coronary artery. After using intravascular
ultrasound to appropriately size the artery, thrombectomy and
placement of a biliary stent were used to treat the lesion with excellent
angiographic outcome.
J INVASIVE CARDIOL 2008;20:E48–E51
Case Report. A 30-year-old male with no previous medical history presented to an emergency department at a community hospital with left-sided, substernal chest pain. The pain was pressure-like and nonradiating. It began shortly after performing weight-lifting activity and lasted for more than 2 hours. In the emergency department, the patient was initially treated medically with aspirin and intravenous nitroglycerin, resulting in partial relief of the chest pain. The patient was hemodynamically stable and physical examination, including cardiac auscultation, was unremarkable. An electrocardiogram showed normal sinus rhythm with 0.2 mV ST-segment depression in the inferior leads associated with deep T-wave inversions. A troponin-I assay was markedly positive with a value of 52.9 mg/dl (normal reference: < 0.4 mg/dl). In addition, a fasting lipid panel revealed severe dyslipidemia with a low-density lipoprotein level (LDL) of 255 mg/dl and a highdensity lipoprotein level (HDL) of 24 mg/dl. The patient was diagnosed as having a non-ST-segment elevation myocardial infarction (NSTEMI) and was subsequently treated with unfractionated heparin, clopidogrel, metoprolol and atorvastatin. A diagnostic cardiac catheterization was performed 48 hours into his initial presentation after transfer to a tertiary care facility. Selective arteriography of the left coronary arteries was performed with a 6 Fr Judkins Left 4 (JL-4) diagnostic catheter (Medtronic, Inc., Minneapolis, Minnesota). The left main coronary artery was angiographically normal. There was a 30% stenosis in the mid-portion of the left anterior descending artery after the second diagonal branch. The left circumflex artery was angiographically normal. A 6 Fr Judkins Right 4 (JR-4) Launcher guide catheter (Medtronic) was advanced to the ostium of the right coronary artery (RCA). Contrast injection of the RCA revealed a very large-caliber dominant vessel. A large filling defect, consistent with TIMI grade 4 thrombus, was visible from the mid-portion of the vessel extending down into the posterolateral ventricular (PLV) and posterior descending artery (PDA) branches (Figure 1). There was good flow of contrast around the thrombus and TIMI 3 flow in the distal vessel.
Figure 2.
|  | | An Asahi Prowater guidewire and Maverick 3.0 x 20 mm balloon in the right coronary artery (A). Appearance of the vessel after balloon inflation and multiple passes with the aspiration catheter (B). |
Figure 1.
|  | | LAO view of grade 4 thrombus in the middle and distal right coronary artery (RCA). A 5 Fr temporary pacemaker wire is present in the right ventricle (A). RAO cranial view of the RCA (B). |
After obtaining central venous access through the right femoral vein, a 5 Fr Pacel™ balloon-tipped temporary pacemaker wire (St. Jude Medical, Minnetonka, Minnesota) was advanced into the right ventricular apex from the right femoral vein and found to have adequate capture. Intraprocedural anticoagulation was achieved with a bolus (0.75 mg/kg calculated to 82.5 mg) and infusion (1.75 mg/kg/hour calculated as 192.5 mg/hour) of bivalirudin (Angiomax®, The Medicines Company, Parsippany, New Jersey). In addition, a bolus (180 μg/kg calculated to 20.4 mg) and infusion (2 μg/kg/minute calculated to 13.6 mg/hour) of eptifibatide (Integrelin®, Schering-Plough, Kenilworth, New Jersey) were administered. A Maverick® 3.0 mm x 12 mm Rapid Exchange angioplasty balloon (Boston Scientific, Natick, Massachusetts) was advanced over an Asahi Prowater 0.014 inch x 180 cm guidewire (Abbott Laboratories, Abbott Park, Illinois), which had been previously positioned in the PLV branch. The balloon was inflated to 12 atm for 30 seconds at the proximal portion of the filling defect (Figure 2A). Balloon angioplasty was attempted initially to ascertain the diameter and length of the lesion to facilitate stent placement. In addition, angioplasty was performed with the intention of facilitating passage of a thrombectomy catheter, given that the patient presented for coronary angiography 36 hours after his initial symptoms and the increased likelihood of organized thrombus. Test injections showed no significant distal embolization and the patient maintained a sinus rhythm (Figure 2B). A Pronto aspiration catheter (Vascular Solutions, Minneapolis, Minnesota) was then advanced over the guidewire to the bifurcation of the PLV and PDA branches. Distal-to-proximal aspiration was performed twice and multiple fragments of thrombus were obtained. Notably, the filling defect was much smaller in appearance, especially in the mid-portion of the vessel (Figure 2C). Quantitative coronary analysis of the vessel documented a vessel diameter of 5.6 mm. We performed intravascularultrasound (IVUS) with the 2.9 Fr 150 cm Eagle Eye Gold catheter (Volcano Therapeutics, Rancho Cordova, California) to verify the size of the vessel. IVUS demonstrated a luminal diameter of 8 mm in the mid-portion of the vessel with a large amount of thrombus and soft plaque (Figure 3). The distal vessel, including the bifurcation of the PLV and PDA branches, appeared to contain a high burden of thrombus (Figure 2C).
Figure 4.
|  | | A 8.0 x 27 mm Express bare-metal biliary stent deployed in the midright coronary artery (A,B) with a good angiographic result (C). |
Figure 3.
|  | | Intravascular ultrasound of the mid-right coronary artery. Soft plaque and thrombus are encroaching on the lumen of the vessel, as demonstrated. |
After thrombectomy, a large degree of thrombus was still present and overlying a 75% stenotic lesion. Therefore, we opted to place a stent over the mid-portion of the RCA in order to prevent future clot embolization and propagation. The 6 Fr JR-4 Launcher guide catheter was exchanged for an 8 Fr Launcher JR-4 guide catheter (Medtronic). The mid-RCA lesion was recrossed with an Extra S’port 0.014 inch x 300 cm guidewire (Guidant Corp., Santa Clara, California). An 8.0 x 27 mm balloon-expandable Express Biliary stent (Boston Scientific Corp., Natick, Massachusetts) was deployed at 8 atm (for a final diameter of 8.0 mm) to the mid-RCA without complication (Figure 4). The patient subsequently received 48 hours of treatment with eptifibatide. Repeat catheterization was performed revealing continued presence of filling defects and TIMI grade 4 thrombus at the bifurcation of the PLV and PDA branches (Figure 5). After using Angiomax in the same fashion as above, an 8 Fr Launcher JR-4 guide catheter was advanced into the ascending aorta and engaged into the ostium of the RCA. A 0.014 inch x 180 cm Asahi Prowater guidewire was placed in the PLV and another identical wire was placed in the PDA. The ostium of the PDA was dilated with a 3.0 x 12 mm Maverick balloon to 12 atm. Then a 5.0 x 20 mm Liberté stent (Boston Scientific) was deployed at 18 atm (for a final diameter of > 5.62 mm). Further injections revealed a 90% stenosis at the ostium of the PDA. Dilatation of this lesion with a 3.0 x 9.0 mm Maverick balloon at 16 atm was followed by the deployment of a 4.0 x 12 mm Liberté stent at 14 atm (for a final diameter of 4.36 mm), resulting in the treatment of this bifurcation with the “T-stent” technique. There was TIMI 3 flow, no dissection and no residual thrombus in the distal RCA (Figure 6). The patient had an uneventful hospital course and has had no further recurrence of his chest pain.
Figure 6.
|  | | An Asahi Prowater guidewire sits in the PLV after deployment of a 5.0 x 20 mm Liberté stent (A). After stent deployment, there was significant plaque shift in addition to the baseline stenosis of the ostum of the PDA (B), which was succesfully treated with a 4.0 x 12 mm Liberté stent (C). |
Figure 5.
|  | | Appearance of the right coronary artery (RCA) after placement of an Express biliary stent and 48 hours of Integrelin treatment. Note the continued presence of severe TIMI grade 4 thrombus in the distal RCA at the bifurcation of the PLV and PDA branches. |
|
|
| The Journal of Invasive Cardiology - ISSN: 1042-3931 - Volume 20 - Issue 2 - February 2008 - Pages: E48 - E51 | |
|
Create a Successful Vena Cava Filter Practice
Accredited CD
This activity is supported by an educational grant from Cook Incorporated and has been designed for Interventional Cardiologists, Vascular Surgeons, Fellows and Interventional Cardiovascular Nurses and Technologists.
|
| |
|
|
|
|
Achieving Optimal Outcomes in Carotid Stenting: Lessons Learned from Recent Clinical Trials
Complimentary Accredited ON DEMAND Webcast
Topics
1. EVA-3S & Space-Bumps in the road
2. CAPTURE 3500-Lesion morphology & Predictors for Stroke
3. CAPTURE II vs. EXACT 1500-Does open or Closed Cell Stent design really matter?
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Neurologists, Interventional Nurses and Technologists with an interest in the diagnosis and treatment of peripheral artery disease. |
|
Anticoagulation Techniques for Peripheral Vascular Interventions
Complimentary Accredited ON DEMAND Webcast
This activity has been developed for Interventional Cardiologists, Vascular Surgeons, Interventional Radiologists, Podiatric Physicians, Endovascular Allied Professionals, Endocrinologists, Wound Care Specialists, Directors of the Wound Care Clinic, and Primary Care Physicians, Pharmacists, Nurses and Technologists.
|
|
|
|
|
|
March 2007 Supplement
|
On-Demand Webcast
|
Archived Webcast
|
|
|
|
|
|
About HMP Communications
HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC, which also owns the North American Center for Continuing Medical Education (NACCME). NACCME provides a wide array of accredited CME offerings with industry thought leaders participating in roundtable meetings, webcasts, symposia, conferences, seminars, podcasts and satellite programs. Discover more about HMP’s products and services at www.hmpcommunications.com. ©2008 HMP Communications |
© 2008 HMP Communications | All Rights Reserved
83 General Warren Blvd, Suite 100 | Malvern, PA 19355 | 800.237.7285
|
|
| | |